Precision Psychiatry Market Size, Share & Trends Analysis Report By Product Type (Products, Services), By Sample Type (Blood-Based, Non-Blood-Based), By Biomarker Type (Genetic Biomarker, Protein Biomarker), By Technology (Sequencing (NGS and Traditional Sequencing), Polymerase Chain Reaction (RT-PCR and dPCR), Microarray, Immunoassay, Liquid Chromatography/Mass Spectrometry), By Application (Alzheimer’s Disease, Parkinson’s Disease, Autism, Depression, Bipolar Disease), By End User (Academic and Research Institutions, Hospitals and Diagnostic Laboratories) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR2122DR | Pages: 110

Market Segmentation

  1. Precision Psychiatry Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Products
    2. Services
  2. Precision Psychiatry Market, By Sample Type  2022-2034 (USD MILLION/ Units)
    1. Blood-Based
    2. Non-Blood-Based
  3. Precision Psychiatry Market, By Biomarker Type 2022-2034 (USD MILLION/ Units)
    1. Genetic Biomarker
    2. Protein Biomarker
  4. Precision Psychiatry Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Sequencing (NGS and Traditional Sequencing)
    2. Polymerase Chain Reaction (RT-PCR and dPCR)
    3. Microarray
    4. Immunoassay
    5. Liquid Chromatography/Mass Spectrometry
  5. Precision Psychiatry Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Alzheimer’s Disease
    2. Parkinson’s Disease
    3. Autism
    4. Depression
    5. Bipolar Disease
  6. Precision Psychiatry Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Academic and Research Institutions
    2. Hospitals and Diagnostic Laboratories
  7. Regional Precision Psychiatry Market
    1. North America
      1. North America Precision Psychiatry Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Products
        2. Services
      2. North America Precision Psychiatry Market By Sample Type  2022-2034 (USD MILLION/ Units)
        1. Blood-Based
        2. Non-Blood-Based
      3. North America Precision Psychiatry Market By Biomarker Type 2022-2034 (USD MILLION/ Units)
        1. Genetic Biomarker
        2. Protein Biomarker
      4. North America Precision Psychiatry Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Sequencing (NGS and Traditional Sequencing)
        2. Polymerase Chain Reaction (RT-PCR and dPCR)
        3. Microarray
        4. Immunoassay
        5. Liquid Chromatography/Mass Spectrometry
      5. North America Precision Psychiatry Market By Application 2022-2034 (USD MILLION/ Units)
        1. Alzheimer’s Disease
        2. Parkinson’s Disease
        3. Autism
        4. Depression
        5. Bipolar Disease
      6. North America Precision Psychiatry Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutions
        2. Hospitals and Diagnostic Laboratories
      7. U.S.
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      8. Canada
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
    2. Europe
      1. Europe Precision Psychiatry Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Products
        2. Services
      2. Europe Precision Psychiatry Market By Sample Type  2022-2034 (USD MILLION/ Units)
        1. Blood-Based
        2. Non-Blood-Based
      3. Europe Precision Psychiatry Market By Biomarker Type 2022-2034 (USD MILLION/ Units)
        1. Genetic Biomarker
        2. Protein Biomarker
      4. Europe Precision Psychiatry Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Sequencing (NGS and Traditional Sequencing)
        2. Polymerase Chain Reaction (RT-PCR and dPCR)
        3. Microarray
        4. Immunoassay
        5. Liquid Chromatography/Mass Spectrometry
      5. Europe Precision Psychiatry Market By Application 2022-2034 (USD MILLION/ Units)
        1. Alzheimer’s Disease
        2. Parkinson’s Disease
        3. Autism
        4. Depression
        5. Bipolar Disease
      6. Europe Precision Psychiatry Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutions
        2. Hospitals and Diagnostic Laboratories
      7. U.K.
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      8. Germany
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      9. France
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      10. Spain
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      11. Italy
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      12. Russia
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      13. Nordic
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      14. Benelux
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      15. Rest of Europe
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
    3. APAC
      1. APAC Precision Psychiatry Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Products
        2. Services
      2. APAC Precision Psychiatry Market By Sample Type  2022-2034 (USD MILLION/ Units)
        1. Blood-Based
        2. Non-Blood-Based
      3. APAC Precision Psychiatry Market By Biomarker Type 2022-2034 (USD MILLION/ Units)
        1. Genetic Biomarker
        2. Protein Biomarker
      4. APAC Precision Psychiatry Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Sequencing (NGS and Traditional Sequencing)
        2. Polymerase Chain Reaction (RT-PCR and dPCR)
        3. Microarray
        4. Immunoassay
        5. Liquid Chromatography/Mass Spectrometry
      5. APAC Precision Psychiatry Market By Application 2022-2034 (USD MILLION/ Units)
        1. Alzheimer’s Disease
        2. Parkinson’s Disease
        3. Autism
        4. Depression
        5. Bipolar Disease
      6. APAC Precision Psychiatry Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutions
        2. Hospitals and Diagnostic Laboratories
      7. China
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      8. Korea
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      9. Japan
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      10. India
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      11. Australia
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      12. Taiwan
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      13. South East Asia
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      14. Rest of Asia-Pacific
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
    4. Middle East and Africa
      1. Middle East and Africa Precision Psychiatry Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Products
        2. Services
      2. Middle East and Africa Precision Psychiatry Market By Sample Type  2022-2034 (USD MILLION/ Units)
        1. Blood-Based
        2. Non-Blood-Based
      3. Middle East and Africa Precision Psychiatry Market By Biomarker Type 2022-2034 (USD MILLION/ Units)
        1. Genetic Biomarker
        2. Protein Biomarker
      4. Middle East and Africa Precision Psychiatry Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Sequencing (NGS and Traditional Sequencing)
        2. Polymerase Chain Reaction (RT-PCR and dPCR)
        3. Microarray
        4. Immunoassay
        5. Liquid Chromatography/Mass Spectrometry
      5. Middle East and Africa Precision Psychiatry Market By Application 2022-2034 (USD MILLION/ Units)
        1. Alzheimer’s Disease
        2. Parkinson’s Disease
        3. Autism
        4. Depression
        5. Bipolar Disease
      6. Middle East and Africa Precision Psychiatry Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutions
        2. Hospitals and Diagnostic Laboratories
      7. UAE
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      8. Turkey
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      9. Saudi Arabia
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      10. South Africa
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      11. Egypt
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      12. Nigeria
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      13. Rest of MEA
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
    5. LATAM
      1. LATAM Precision Psychiatry Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Products
        2. Services
      2. LATAM Precision Psychiatry Market By Sample Type  2022-2034 (USD MILLION/ Units)
        1. Blood-Based
        2. Non-Blood-Based
      3. LATAM Precision Psychiatry Market By Biomarker Type 2022-2034 (USD MILLION/ Units)
        1. Genetic Biomarker
        2. Protein Biomarker
      4. LATAM Precision Psychiatry Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Sequencing (NGS and Traditional Sequencing)
        2. Polymerase Chain Reaction (RT-PCR and dPCR)
        3. Microarray
        4. Immunoassay
        5. Liquid Chromatography/Mass Spectrometry
      5. LATAM Precision Psychiatry Market By Application 2022-2034 (USD MILLION/ Units)
        1. Alzheimer’s Disease
        2. Parkinson’s Disease
        3. Autism
        4. Depression
        5. Bipolar Disease
      6. LATAM Precision Psychiatry Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutions
        2. Hospitals and Diagnostic Laboratories
      7. Brazil
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      8. Mexico
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      9. Argentina
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      10. Chile
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      11. Colombia
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
      12. Rest of LATAM
        1. Products
        2. Services
        3. Blood-Based
        4. Non-Blood-Based
        5. Genetic Biomarker
        6. Protein Biomarker
        7. Sequencing (NGS and Traditional Sequencing)
        8. Polymerase Chain Reaction (RT-PCR and dPCR)
        9. Microarray
        10. Immunoassay
        11. Liquid Chromatography/Mass Spectrometry
        12. Alzheimer’s Disease
        13. Parkinson’s Disease
        14. Autism
        15. Depression
        16. Bipolar Disease
        17. Academic and Research Institutions
        18. Hospitals and Diagnostic Laboratories
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: